Secretive Expression and Establishment of ELISA Determination of Connective Tissue Growth Factor

刘乃丰,吴国球,孙宏伟,黄立新,张粉梅,钱娟英,卢惠霞

DOI: https://doi.org/10.3969/j.issn.1001-764x.2005.01.002

2005-01-01

Abstract:Objective To produce connective tissue growth factor (CTGF) standard material and establish the method for determination of CTGF.Method Total RNA was extracted from human endothelial cells and was reverse-transcripted into cDNA.The gene encoded CTGF C region 242-349 residues was obtained by PCR with designed primers and inserted to upstream of the gene of phage coat protein Ⅲ.The CTGF fused protein was expressed and rabbits were immunized to produce antibody after purification.The purified antibody was conjugated with horseperoxidase (HRP),and used to establish an ELISA method.The established method was evaluated according to its sensitivity,precision,recovery,interference and etc.For the investigation of relevance between CTGF and diseases 162 clinical samples were tested.Result The gene of CTGF C region was successfully cloned and inserted into expressive vector to obtain the fused protein of 25 kD by induced IPTG.The required protein was identified by immunological method.The antibody was effectively labeled with HRP.The sensitivity of this method was 2 ng/ml.The average intra-assay and inter-assay precision were 5.38% and 7.50% respectively.The average recovery was 104.23%.The concentrations of hemoglobin (0-50mmol/L),total bilirubin (0-150 μmol/L),triglyceride (0-2.0mmol/L) did not interfere the test result.The result of clinical application showed that two blood samples from chronic hepatitis and urine samples from 5 diabetic nephropathy patients,3 renal failure patients and 2 chronic nephritis patients were CTGF-positive.Conclusion CTGF was a new marker and is closely related to the formation,development and prognosis of fibrosis.Successful establishment of ELISA method for detection of CTGF paved a way for its clinical application.